B. Lenzi

480 total citations
9 papers, 86 citations indexed

About

B. Lenzi is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, B. Lenzi has authored 9 papers receiving a total of 86 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in B. Lenzi's work include Liver Disease and Transplantation (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). B. Lenzi is often cited by papers focused on Liver Disease and Transplantation (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). B. Lenzi collaborates with scholars based in Italy and United States. B. Lenzi's co-authors include Franco Trevisani, Mauro Bernardi, Maurizio Biselli, Marco Domenicali, Paolo Caraceni, Francesca Garuti, Mario Cavazza, A. Zambruni, Antonio Di Micoli and Alessandro Cucchetti and has published in prestigious journals such as Journal of Hepatology, Frontiers in Immunology and Cancer Letters.

In The Last Decade

B. Lenzi

8 papers receiving 81 citations

Peers

B. Lenzi

HEPAT

EPIDE

SURGE

ONCOL

CCM

Iqtedar A Muazzam United Kingdom

Zhen Yu Wong United Kingdom

Antoine Boustany United States

Taku Shigesawa Japan

Daniele Cusi Italy

Audronė Vaitiekienė Lithuania

Shinn Yeung Australia

José María Jover Spain

Emmanuel Selvaraj United Kingdom

Guillaume Conroy France

Iqtedar A Muazzam United Kingdom

B. Lenzi

86 ×1.4

HEPAT

72 ×1.4

EPIDE

19 ×0.8

SURGE

21 ×1.3

ONCOL

8 ×0.7

CCM

Citations per year, relative to B. Lenzi B. Lenzi (= 1×) peers Iqtedar A Muazzam

Countries citing papers authored by B. Lenzi

Since Specialization

Citations

This map shows the geographic impact of B. Lenzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Lenzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Lenzi more than expected).

Fields of papers citing papers by B. Lenzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Lenzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Lenzi. The network helps show where B. Lenzi may publish in the future.

Co-authorship network of co-authors of B. Lenzi

This figure shows the co-authorship network connecting the top 25 collaborators of B. Lenzi. A scholar is included among the top collaborators of B. Lenzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Lenzi. B. Lenzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Andrini, Elisa, Rita Rinaldi, Tania Silvestri, et al.. (2025). Baseline neuronal antibodies in patients with small cell lung cancer are not necessarily associated with post-immune checkpoint inhibitors neurotoxicities. Frontiers in Immunology. 16. 1681765–1681765.

2.

Giglio, Andrea De, Elisa Tassinari, Alessandro Di Federico, et al.. (2022). The Palliative Prognostic (PaP) Score without Clinical Evaluation Predicts Early Mortality among Advanced NSCLC Patients Treated with Immunotherapy. Cancers. 14(23). 5845–5845. 5 indexed citations

3.

Federico, Alessandro Di, B. Lenzi, Elisabetta Nobili, et al.. (2021). Critical diagnostic delay associated with unusual presentation of hepatocellular carcinoma (HCC) with orbital metastases: a case report. Annals of Palliative Medicine. 10(7). 8474–8478. 2 indexed citations

4.

Federico, Alessandro Di, et al.. (2020). Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible?. Anti-Cancer Drugs. 31(10). 1103–1105. 5 indexed citations

5.

Biselli, Maurizio, Annagiulia Gramenzi, B. Lenzi, et al.. (2018). Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding. Clinical Gastroenterology and Hepatology. 17(7). 1388–1397.e1. 11 indexed citations

6.

Trevisani, Franco, Francesca Garuti, Alessandro Cucchetti, B. Lenzi, & Mauro Bernardi. (2014). De novo hepatocellular carcinoma of liver allograft: A neglected issue. Cancer Letters. 357(1). 47–54. 16 indexed citations

7.

Trevisani, Franco, Antonio Di Micoli, A. Zambruni, et al.. (2012). QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. Liver International. 32(10). 1510–1515. 38 indexed citations

8.

Lenzi, B., et al.. (2011). 552 COGNITIVE PROFILES IN PATIENTS WITH CIRRHOSIS AND LONG-TERM LIVER TRANSPLANT RECIPIENTS. Journal of Hepatology. 54. S225–S225. 1 indexed citations

9.

Pansini, F., et al.. (1986). Serum CA 125 in Ovarian Pathology and Its Variation in Ovarian Carcinoma after Integrated Therapy. Gynecologic and Obstetric Investigation. 21(1). 47–51. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact